NovoBliss Research Private Limited

NovoBliss Research Private Limited is an Ahmedabad-based Contract Research Organization (CRO) specializing in scientifically validated clinical safety and efficacy testing. The company operates a 12,000 sq. ft. facility equipped with advanced bio-analytical instrumentation to conduct in-vitro, ex-vivo, and Phase I-IV clinical trials. Their service portfolio spans pharmaceuticals, nutraceuticals, dermatology, cosmetics, medical devices, and personal healthcare, utilizing standardized methodologies that align with global regulatory requirements, including CDSCO, FDA, and ICH-GCP guidelines. Founded by Dr. Nayan Patel and Dr. Maheshvari Patel, the firm integrates clinical research with medical writing, biostatistics, and regulatory support to deliver data-driven evidence for product development and claim substantiation.

This research expertise is critical for healthcare and consumer brands seeking to validate product performance and ensure global regulatory compliance. By bridging traditional knowledge with modern clinical science, the company assists partners in transforming research findings into publication-ready, compliant, and market-ready documentation. NovoBliss maintains ISO 9001:2015 certification and membership in professional bodies like the Indian Society for Clinical Research and the Advertising Standards Council of India, reinforcing its commitment to ethical research conduct, data integrity, and reproducibility across global markets.